Year: 2021
Type: article
Abstract: Equally contributed to the work ReviewAdaptive designs in oncology drug investigation, especially in the clinical trials of anti-cancer agents, have become more and more popular with the advantages of high efficiency and cost-effectiveness.However, potential success of the adaptive trial relies on the thorough understanding of adaptive design, exhaustive preprotocols backup, proficient statistical skills and support from local regulators.Here We reviewed the definitions of adaptive design trial (ADT) from previous publications, listed the advantages and drawbacks of different ADT approaches compared to traditional RCTs.Next, we collected all the clinical trials with adaptive design, exhibited a landscape of registered ADTs yearly and policies/instructions aiming to accelerate drug approval and commercialization across the world to date.Furthermore, we focus on the utilization of master protocol design in the field of solid tumor and analyzed the pros and cons of multiple key ADT studies around the world.Finally, we proposed an optimal PLATFORM study protocol with adaptive master protocol design based on all the elements we listed above and concluded the importance and potential future applications of adaptive trial design.
Source: Clinical Research and Trials
DOI: 10.15761/crt.1000353
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: diamond
OpenAlex ID: W3210175945
